Medtronic, a global leader in healthcare technology, today announced the appointment of Kate Benedict as senior vice president and president of the company’s Acute Care & Monitoring (ACM) business, where she will also serve on the Medical Surgical Portfolio leadership team.

“Kate is an inspirational and strategic leader with a proven track record of driving innovation and growth across the healthcare industry,” said Mike Marinaro, executive vice president and president of the Medical Surgical Portfolio at Medtronic. “Her people-first, patient-centric leadership style and deep experience across the industry make her uniquely suited to lead ACM as we revolutionize the future of healthcare to alleviate pain, restore health, and extend life.”

Benedict brings to Medtronic more than 25 years of experience in the healthcare sector, spanning medical devices, diagnostics, pharmaceuticals, and drug delivery. She is known for delivering innovative solutions that drive above-market growth, strategic portfolio management, and operational efficiency.

“I am honored to join Medtronic and lead an organization so deeply committed to patient safety and innovation,” said Benedict. “ACM’s vision to personalize patient care, anytime, anywhere motivates me, and I’m excited to support our teams in delivering world-class technology that empowers healthcare professionals and improves outcomes for patients around the world.”

Prior to joining Medtronic, Benedict served as president of the global Health Solutions business at Flex. She also previously held executive roles at BD, Alcon, and Johnson & Johnson. She began her career as an auditor at KPMG, where she earned her Certified Public Accountant (CPA) license.

Benedict earned an MBA in Marketing and International Business from Rutgers University and a Bachelor of Science in Accounting from the University of Delaware.

About Medtronic

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:
Catherine Bosin
Communications
+1-773-459-6579

Ryan Weispfenning
Investor Relations
+1-763-505-4626